Authors:
Littlewood, TJ
Bajetta, E
Nortier, JWR
Vercammen, E
Rapoport, B
Citation: Tj. Littlewood et al., Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized,double-blind, placebo-controlled trial, J CL ONCOL, 19(11), 2001, pp. 2865-2874
Citation: Hfa. Vasen et al., Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?, AM J HU GEN, 68(6), 2001, pp. 1533-1534
Citation: Soa. Shamelian et Jwr. Nortier, Extrapulmonary small-cell carcinoma: report of three cases and update of therapy and prognosis, NETH J MED, 56(2), 2000, pp. 51-55
Authors:
van Toorn, DW
Nortier, JWR
Rubach, M
de Swart, CAM
Huldij, JC
van Tinteren, H
Vermorken, JB
Citation: Dw. Van Toorn et al., Randomized phase II study of FEC day 1+8 and FEC day 1 in patients with advanced breast cancer, BREAST CANC, 60(1), 2000, pp. 57-62
Authors:
Nabholtz, JM
Senn, HJ
Bezwoda, WR
Melnychuk, D
Deschenes, L
Douma, J
Vandenberg, TA
Rapoport, B
Rosso, R
Trillet-Lenoir, V
Drbal, J
Molino, A
Nortier, JWR
Richel, DJ
Nagykalnai, T
Siedlecki, P
Wilking, N
Genot, JY
Hupperets, PSGJ
Pannuti, F
Skarlos, D
Tomiak, EM
Murawsky, M
Alakl, M
Riva, A
Aapro, M
Citation: Jm. Nabholtz et al., Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy, J CL ONCOL, 17(5), 1999, pp. 1413-1424